Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approval
Pharma
EU authorities revoke marketing nod for Advanz Pharma's Ocaliva
In light of the suspension being lifted, Ocaliva’s European marketing nod has been revoked “with immediate effect,” Advanz said.
Fraiser Kansteiner
Dec 2, 2024 2:54pm
Verona earns FDA nod for potential blockbuster to treat COPD
Jun 26, 2024 6:26pm
Botanix' excessive sweat treatment Sofdra gains FDA approval
Jun 20, 2024 5:34pm
Lack of global regulatory alignment spurs bad actors, FDA says
May 9, 2024 10:15am
Biogen and Reata build their blockbuster case for Skyclarys
Feb 12, 2024 5:05pm
TG locks up international marketing partner for MS drug Briumvi
Aug 1, 2023 9:15am
